WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VYGR

Based on 6 analysts offering 12 month price targets for Voyager Therapeutics Inc

Min Forecast
$5.73+47.49%
Avg Forecast
$14.12+263.5%
Max Forecast
$30.00+672.2%

Should I buy or sell VYGR stock?

Based on 6 analysts offering ratings for Voyager Therapeutics Inc.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although VYGR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates VYGR as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their VYGR stock forecasts and price targets.

VYGR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-13
lockedlocked$00.00+00.00%2025-03-13
lockedlocked$00.00+00.00%2025-03-12
lockedlocked$00.00+00.00%2025-01-10
lockedlocked$00.00+00.00%2024-12-02
Leerink Partners
Bottom 25%
25
BuyInitiates Coverage On$15.00+286.10%2024-10-16

1 of 1

Forecast return on equity

Is VYGR forecast to generate an efficient return?

Company
-8.61%
Industry
143.45%
Market
89.58%
VYGR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VYGR forecast to generate an efficient return on assets?

Company
-6.57%
Industry
32.63%
VYGR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VYGR earnings per share forecast

What is VYGR's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.41
Avg 2 year Forecast
-$1.40
Avg 3 year Forecast
-$1.39

VYGR revenue forecast

What is VYGR's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$89.3M+11.64%
Avg 2 year Forecast
$86.4M+7.94%
Avg 3 year Forecast
$76.3M-4.67%
VYGR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VYGR revenue growth forecast

How is VYGR forecast to perform vs Biotechnology companies and vs the US market?

Company
-1.07%
Industry
59.81%
Market
10.82%
VYGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VYGR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VYGR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VYGR$3.89$14.12+263.50%Strong Buy
ELDN$3.54$16.00+351.98%Buy
NVCT$9.44$15.00+58.90%Strong Buy
DMAC$5.21$7.00+34.36%Buy
YMAB$4.54$16.50+263.44%Buy
View Top Biotech Stocks

Voyager Therapeutics Stock Forecast FAQ

Is Voyager Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: VYGR) stock is to Strong Buy VYGR stock.

Out of 6 analysts, 4 (66.67%) are recommending VYGR as a Strong Buy, 2 (33.33%) are recommending VYGR as a Buy, 0 (0%) are recommending VYGR as a Hold, 0 (0%) are recommending VYGR as a Sell, and 0 (0%) are recommending VYGR as a Strong Sell.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.

What is VYGR's earnings growth forecast for 2025-2027?

(NASDAQ: VYGR) Voyager Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.95%.

Voyager Therapeutics's earnings in 2025 is -$65,002,000.On average, 7 Wall Street analysts forecast VYGR's earnings for 2025 to be -$77,681,608, with the lowest VYGR earnings forecast at -$124,215,491, and the highest VYGR earnings forecast at -$33,676,200. On average, 6 Wall Street analysts forecast VYGR's earnings for 2026 to be -$77,013,605, with the lowest VYGR earnings forecast at -$124,767,560, and the highest VYGR earnings forecast at -$27,051,374.

In 2027, VYGR is forecast to generate -$76,737,570 in earnings, with the lowest earnings forecast at -$108,205,495 and the highest earnings forecast at -$51,342,403.

What is VYGR's revenue growth forecast for 2025-2027?

(NASDAQ: VYGR) Voyager Therapeutics's forecast annual revenue growth rate of -1.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.82%.

Voyager Therapeutics's revenue in 2025 is $80,001,000.On average, 5 Wall Street analysts forecast VYGR's revenue for 2025 to be $4,930,692,520, with the lowest VYGR revenue forecast at $220,827,540, and the highest VYGR revenue forecast at $8,064,014,485. On average, 5 Wall Street analysts forecast VYGR's revenue for 2026 to be $4,767,445,761, with the lowest VYGR revenue forecast at $220,827,540, and the highest VYGR revenue forecast at $8,112,651,751.

In 2027, VYGR is forecast to generate $4,210,187,464 in revenue, with the lowest revenue forecast at $220,827,540 and the highest revenue forecast at $6,780,123,168.

What is VYGR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VYGR) forecast ROA is -6.57%, which is lower than the forecast US Biotechnology industry average of 32.63%.

What is VYGR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year VYGR price target, the average VYGR price target is $14.12, with the highest VYGR stock price forecast at $30.00 and the lowest VYGR stock price forecast at $5.73.

On average, Wall Street analysts predict that Voyager Therapeutics's share price could reach $14.12 by Mar 13, 2026. The average Voyager Therapeutics stock price prediction forecasts a potential upside of 263.5% from the current VYGR share price of $3.89.

What is VYGR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: VYGR) Voyager Therapeutics's current Earnings Per Share (EPS) is -$1.13. On average, analysts forecast that VYGR's EPS will be -$1.41 for 2025, with the lowest EPS forecast at -$2.25, and the highest EPS forecast at -$0.61. On average, analysts forecast that VYGR's EPS will be -$1.40 for 2026, with the lowest EPS forecast at -$2.26, and the highest EPS forecast at -$0.49. In 2027, VYGR's EPS is forecast to hit -$1.39 (min: -$1.96, max: -$0.93).

What is VYGR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VYGR) forecast ROE is -8.61%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.